Scan to Download
One power score. Smarter investment decisions
Immix Biopharma Inc
IMMX2.190USD
+0.100+4.78%
收盤 09/19, 16:00（美東）報價延遲15分鐘
USD0.000盤後交易 (美東)
62.21M總市值
虧損本益比TTM
單季報
單季報+年報
單季報
年報
YOY
隱藏空白列
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2020Q4
FY2020Q3
營業費用
42.85%6.72M
-16.23%4.68M
-7.23%4.99M
63.47%7.39M
26.39%4.70M
121.76%5.59M
41.67%5.38M
195.02%4.52M
138.36%3.72M
89.52%2.52M
534.19%3.79M
340.64%1.53M
--1.56M
--1.33M
289.57%598.34K
281.42%347.99K
--153.59K
--91.23K
研發費用
78.61%3.97M
-39.20%1.98M
-55.68%1.37M
111.09%4.45M
0.67%2.22M
146.29%3.25M
37.05%3.10M
202.62%2.11M
263.51%2.21M
109.52%1.32M
24397.17%2.26M
2244.01%695.94K
--607.75K
--629.53K
-88.92%9.24K
-33.96%29.69K
--83.33K
--44.96K
折舊攤銷及損耗
228.61%79.83K
1866.11%59.18K
1243.86%41.34K
1775.89%25.91K
4701.38%24.30K
496.04%3.01K
443.46%3.08K
143.99%1.38K
32.11%506.00
-18.55%505.00
-8.71%566.00
-8.71%566.00
--383.00
--620.00
6.71%620.00
6.90%620.00
--581.00
--580.00
營業利潤
-42.85%-6.72M
16.23%-4.68M
7.23%-4.99M
-63.47%-7.39M
-26.39%-4.70M
-121.76%-5.59M
-41.67%-5.38M
-195.02%-4.52M
-138.36%-3.72M
-89.52%-2.52M
-534.19%-3.79M
-340.64%-1.53M
---1.56M
---1.33M
-289.57%-598.34K
-281.42%-347.99K
---153.59K
---91.23K
淨非營業利息收入（費用）
利息收入
-66.10%104.06K
-43.93%150.22K
-18.69%185.85K
37.49%256.68K
138.20%306.92K
860.52%267.91K
--228.57K
--186.69K
--128.85K
--27.89K
----
----
----
----
----
----
----
----
利息費用
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
--109.00
--388.00
80.26%44.51K
130.78%53.94K
--24.69K
--23.37K
特殊收入（費用）
----
----
----
----
----
----
----
----
----
----
100.00%0.00
----
----
----
---86.17K
----
----
----
其他非經營性收入（費用）
----
----
----
----
----
----
----
----
----
----
100.00%0.00
--0.00
--0.00
--0.00
-3730.37%-22.02M
-100.00%0.00
---575.01K
--8.00
稅前利潤
-50.46%-6.61M
14.83%-4.53M
6.72%-4.80M
-64.59%-7.14M
-22.38%-4.40M
-113.50%-5.32M
-35.65%-5.15M
-182.85%-4.34M
-130.09%-3.59M
-87.37%-2.49M
83.32%-3.79M
-281.51%-1.53M
---1.56M
---1.33M
-2920.62%-22.75M
-250.73%-401.93K
---753.28K
---114.60K
所得稅
-13.20%8.91K
11.12%9.82K
33.33%10.79K
63.71%11.14K
61.74%10.27K
70.97%8.84K
53.81%8.09K
307.12%6.81K
270.20%6.35K
218.74%5.17K
256.06%5.26K
25.06%1.67K
--1.72K
--1.62K
-87.99%1.48K
-22.31%1.34K
--12.29K
--1.72K
除稅後利潤
-50.31%-6.62M
14.79%-4.54M
6.66%-4.81M
-64.58%-7.15M
-22.45%-4.41M
-113.41%-5.33M
-35.67%-5.16M
-182.98%-4.34M
-130.24%-3.60M
-87.53%-2.50M
83.30%-3.80M
-280.66%-1.54M
---1.56M
---1.33M
-2872.31%-22.76M
-246.69%-403.26K
---765.58K
---116.32K
持續經營利潤
-50.31%-6.62M
14.79%-4.54M
6.66%-4.81M
-64.58%-7.15M
-22.45%-4.41M
-113.41%-5.33M
-35.67%-5.16M
-182.98%-4.34M
-130.24%-3.60M
-87.53%-2.50M
83.30%-3.80M
-280.66%-1.54M
---1.56M
---1.33M
-2872.31%-22.76M
-246.69%-403.26K
---765.58K
---116.32K
歸屬少數股東的淨利潤
100.00%0.00
100.00%0.00
100.00%0.00
100.00%0.00
41.29%-12.91K
-292.38%-72.07K
---65.86K
---63.25K
---22.00K
---18.37K
----
----
----
----
----
----
----
----
歸属于母公司的淨利潤
-50.75%-6.62M
13.62%-4.54M
5.45%-4.81M
-67.02%-7.15M
-22.84%-4.39M
-112.08%-5.26M
-33.94%-5.09M
-178.86%-4.28M
-128.84%-3.58M
-86.15%-2.48M
83.30%-3.80M
-280.66%-1.54M
---1.56M
---1.33M
-2872.31%-22.76M
-246.69%-403.26K
---765.58K
---116.32K
歸屬普通股東的淨利潤
-50.75%-6.62M
13.62%-4.54M
5.45%-4.81M
-67.02%-7.15M
-22.84%-4.39M
-112.08%-5.26M
-33.94%-5.09M
-178.86%-4.28M
-128.84%-3.58M
-86.15%-2.48M
83.30%-3.80M
-280.66%-1.54M
---1.56M
---1.33M
-2872.31%-22.76M
-246.69%-403.26K
---765.58K
---116.32K
基本每股收益
-44.73%-0.22
31.84%-0.15
30.34%-0.16
-5.45%-0.24
35.82%-0.15
-25.75%-0.22
14.45%-0.23
-109.01%-0.23
-111.23%-0.24
-85.27%-0.18
91.36%-0.27
-96.82%-0.11
---0.11
---0.10
-2872.31%-3.16
-246.60%-0.06
---0.11
---0.02
稀釋每股收益
-44.73%-0.22
31.84%-0.15
30.34%-0.16
-5.45%-0.24
35.82%-0.15
-25.75%-0.22
14.45%-0.23
-109.01%-0.23
-111.23%-0.24
-85.27%-0.18
91.36%-0.27
-96.82%-0.11
---0.11
---0.10
-2872.31%-3.16
-246.60%-0.06
---0.11
---0.02
每股派息
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
貨幣單位
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
審計意見
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
